Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
US8242085B2 · kind B2 · utility
71Cited by
3References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2008 |
| Grant date | Aug 14, 2012 |
| Priority date | — |
| Expiry date | Nov 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of formula (I), as described herein, or pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula (I) are useful as anti-viral agents and/or as anti-cancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.